CME and CFTC Clash Over On-Chain Perpetual Futures

The dispute between the CME and the CFTC began when the regulator approved the listing of crypto perps, despite the CME's concerns that these products are mislabeled and misapply the law. The CME claims that perps are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The lawsuit argues that the CFTC is mislabeling the products and therefore misapplying the law, as futures need an end date, whereas perps are designed for traders to take a financial position on an asset's future without any deadlines. The CFTC's decision has sparked frustration among those who support the regulator's reforming agenda, with some voicing outrage at the CME's attack on its own regulator. The CME has a deep influence over commodities and has played a significant role in getting bitcoin futures listed, but its stance on crypto perps is viewed by crypto natives and DeFi enthusiasts as typical of the way large incumbents handle innovation that might threaten their dominance. The future of CFTC-driven perps remains uncertain as the CME readies its case, which includes claims that the agency rubber-stamped the Kalshi application. The CFTC's approach to regulating perps has been criticized, with some arguing that the agency is not prepared to enforce its emerging perps policy properly. The dispute has significant implications for the US approach to the rapidly growing market, with non-US perps volume reportedly growing to $60 trillion in volume last year.